Intracameral mydriatics in phacoemulsification cataract surgery
- 1 December 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 29 (12) , 2366-2371
- https://doi.org/10.1016/s0886-3350(03)00522-4
Abstract
To evaluate intracameral injection of mydriatics in phacoemulsification cataract surgery and compare the results with those of conventional topical mydriatics. Department of Clinical Science/Ophthalmology, Umeå University Hospital, Umeå, Sweden. This prospective randomized double-blind study included 60 patients who were given topical (topical group) or intracameral (intracameral group) mydriatics. The topical mydriatics comprised 3 drops of cyclopentolate 1% and phenylephrine 10% given 15 minutes apart and 150 microL intracameral lidocaine hydrochloride 1% (Xylocaine) and the intracameral mydriatics, placebo eyedrops and 150 microL intracameral cyclopentolate 0.1%, phenylephrine 1.5%, and Xylocaine 1%. The pupil size was recorded preoperatively, throughout surgery, and 1 day and 1 month postoperatively. Preoperative and postoperative corneal endothelial morphology, corneal thickness, intraocular pressure, visual acuity, aqueous cells and flare, phacoemulsification energy, duration of surgery, pulse, blood pressure, and intraoperative sensation of pain and glare were also recorded. With intracameral mydriatics, mydriasis reached 95% +/- 3% (SD) of its final value within 20 seconds. In the intracameral group, the pupils were smaller than in the topical group (mean 6.7 +/- 1.0 mm versus 7.7 +/- 1.0 mm, P<.001) but did not contract intraoperatively. The pupils in the topical group tended to contract, and the difference between groups was significant (P =.0020). The intracameral group reported less glare during the procedure (P<.001). There was no difference in endothelial cell loss, inflammatory reaction, postoperative corneal swelling, or surgical performance between the groups. Intracameral mydriatics were a rapid, effective, and safe alternative to topical mydriatics in phacoemulsification. Their use can simplify preoperative routines and in certain high-risk groups, may reduce the risk for cardiovascular side effects.Keywords
This publication has 27 references indexed in Scilit:
- The Swedish National Cataract Register: A 9‐year reviewActa Ophthalmologica Scandinavica, 2002
- Trends in health service delivery for cataract surgery at a large Australian ophthalmic hospitalClinical & Experimental Ophthalmology, 2001
- Current Trends in Cataract and Refractive Surgery in Japan 1999 SurveyJapanese Journal of Ophthalmology, 2001
- Aqueous humor lidocaine concentrations in topical and intracameral anesthesiaJournal of Cataract & Refractive Surgery, 1998
- Systemic and Ocular Absorption and Antagonist Activity of Topically Applied Cyclopentolate in ManBasic & Clinical Pharmacology & Toxicology, 1998
- Discharging routine phacoemulsification patients at one weekEye, 1997
- Ocular Pharmacokinetics and Pharmacodynamics of Phenylephrine and Phenylephrine Oxazolidine in Rabbit EyesPharmaceutical Research, 1990
- Systemic Absorption of Ophthalmic CyclopentolateAmerican Journal of Ophthalmology, 1989
- Pharmacokinetics of Topically Applied Cyclopentolate HCI and TropicamideOptometry and Vision Science, 1986
- Penetration Routes of Topically Applied Eye MedicationsAmerican Journal of Ophthalmology, 1978